This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Balance Sheet
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Assets
Cash and Equivalents 14.07M 2.67M 1.79M 9.11M
Receivables 548.37K 1.05M 304.95K 507.93K
Inventories 243.52K 0.00 0.00 0.00
Other Current Assets 2.75K 0.00 0.00 0.00
Total Current Assets 15.01M 4.11M 2.47M 10.19M
Property, Plant & Equipment, Gross 2.04M 5.46M 5.75M 6.37M
Accumulated Depreciation & Depletion 1.72M 5.09M 5.36M 5.71M
Property, Plant & Equipment, Net 320.30K 371.10K 392.66K 658.41K
Intangibles 564.54K 813.08K 919.71K 1.15M
Other Non-Current Assets 0.00 748.99K 3.65M 4.52M
Total Non-Current Assets 884.84K 2.23M 5.25M 6.65M
Liabilities & Shareholder Equity
Total Assets 15.89M 6.34M 7.72M 16.84M
Accounts Payable 515.65K 1.14M 927.94K 927.60K
Short Term Debt 0.00 0.00 0.00 18.18K
Other Current Liabilities 425.61K 673.74K 713.28K 758.24K
Total Current Liabilities 1.33M 2.18M 2.29M 1.98M
Long Term Debt 0.00 2.36M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 19.42K 76.52K 89.29K 111.16K
Minority Interest 0.00 -8.73K -47.43K -9.53K
Total Non-Current Liabilities 19.42K 2.43M 201.18K 269.51K
Total Liabilities 1.35M 4.61M 2.49M 2.25M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 14.54M 1.72M 5.23M 14.59M
Common Par 88.39M 84.81M 77.70M 85.29M
Additional Paid In Capital 0.00 0.00 0.00 0.00
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -77.46M -86.78M -76.13M -74.50M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 3.60M 3.69M 3.67M 3.81M
Total Capitalization 14.54M 4.08M 5.23M 14.59M
Total Equity 14.54M 1.72M 5.23M 14.59M
Total Liabilities & Stock Equity 15.89M 6.34M 7.72M 16.84M
Total Common Shares Outstanding 11.44M 4.09M 3.17M 3.10M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 7.15M 3.83M 3.15M 3.07M
Diluted Weighted Shares Outstanding 7.15M 3.83M 3.15M 3.07M
Number of Employees 25 63 64 64
Number of Part-Time Employees 0 0 0 0
GENE News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GENE Genetic Technologies Ltd

Chart of GENE

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GENE ANALYST REPORT

GENE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs